BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10312123)

  • 1. Economic evaluation and the rational diffusion and use of health technology.
    Drummond MF
    Health Policy; 1987 Jun; 7(3):309-24. PubMed ID: 10312123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of health technology: economic issues for health policy and policy issues for economic appraisal.
    Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1593-600. PubMed ID: 8047916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of economic appraisal of health technology in the European Community: report of the network. The EC Network on the Methodology of Economic Appraisal of Health Technology.
    Davies L; Coyle D; Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1601-7. PubMed ID: 8047917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The U.K. NHS economic evaluation database. Economic issues in evaluations of health technology.
    Nixon J; Stoykova B; Glanville J; Christie J; Drummond M; Kleijnen J
    Int J Technol Assess Health Care; 2000; 16(3):731-42. PubMed ID: 11028129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation and health care decision-making.
    Rutten F
    Health Policy; 1996 Jun; 36(3):215-29. PubMed ID: 10158267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardizing economic appraisal of health technology in the European Community.
    Rovira J
    Soc Sci Med; 1994 Jun; 38(12):1675-8. PubMed ID: 8047926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic appraisal in the British National Health Service: implications of recent developments.
    Henshall C; Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1615-23. PubMed ID: 8047919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allocating resources.
    Drummond MF
    Int J Technol Assess Health Care; 1990; 6(1):77-92. PubMed ID: 2113892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for successful evaluation and policy-making toward health care technology on the move: the case of medical lasers.
    Banta HD; Vondeling H
    Soc Sci Med; 1994 Jun; 38(12):1663-74. PubMed ID: 8047925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Researcher-driven versus policy-driven economic appraisal of health technologies: the case of France.
    Moatti JP; Chanut C; Benech JM
    Soc Sci Med; 1994 Jun; 38(12):1625-33. PubMed ID: 8047920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interests in health care technology assessment (HCTA) and HCTA training needs in eight European countries: COMETT-ASSESS.
    Szczepura A; Kankaanpää J
    Soc Sci Med; 1994 Jun; 38(12):1679-88. PubMed ID: 8047927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revolution then evolution: the advance of health economic evaluation in Australia.
    Lopert R; Viney R
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):360-6. PubMed ID: 25444293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
    Laupacis A; Feeny D; Detsky AS; Tugwell PX
    CMAJ; 1992 Feb; 146(4):473-81. PubMed ID: 1306034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes measurement: health state preferences and economic evaluation.
    Oldridge NB
    Assist Technol; 1996; 8(2):94-102. PubMed ID: 10163933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten arguments for a societal perspective in the economic evaluation of medical innovations.
    Jönsson B
    Eur J Health Econ; 2009 Oct; 10(4):357-9. PubMed ID: 19618224
    [No Abstract]   [Full Text] [Related]  

  • 16. Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology.
    Inotai A; Pékli M; Jóna G; Nagy O; Remák E; Kaló Z
    BMC Health Serv Res; 2012 Sep; 12():332. PubMed ID: 22999574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost collection and analysis for health economic evaluation.
    Smith KA; Rudmik L
    Otolaryngol Head Neck Surg; 2013 Aug; 149(2):192-9. PubMed ID: 23641023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Handling time in economic evaluation studies.
    Permsuwan U; Guntawongwan K; Buddhawongsa P
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S50-8. PubMed ID: 24964699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of medical technologies in Sweden.
    Jönsson B
    Soc Sci Med; 1997 Aug; 45(4):597-604. PubMed ID: 9226784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.